FDA Investigator Seifert Seifert, Wayne E
Seifert Seifert, Wayne E has inspections in 1 countries as of 07 Jul 2023. Seifert Seifert, Wayne E has collaborated with a combined 455 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
07 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Belgium
Co-Investigator(s):
Alice S Tsao,
Azza Talaat,
Charisse K Green,
Ephrem Hunde, PhD,
Hamet M Toure, PharmD MPH,
Jacqueline Mdiaz Albertini,
Jose E Melendez, DDC,
Katherine Szestypalow,
Madushini Dharmasena, PhD,
Mra Mcculloughj,
Nancy A Bellamy,
Patsy J Domingo,
Robert D Tollefsen,
Roger F Zabinski,
Simone E Pitts,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tracey L Harris,
Uduak M Inokon,
Wayne E Seifert,
Xiaokuang Lai, PhD,
Zabinski Zabinski, Roger F,
Zhihao Qiu (Peter), PhD
Seifert Seifert, Wayne E's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2022 | EIR | UCB Pharma S.A. - EIR, 2022-02-04 |
February, 2022 | FDA 483 | UCB Pharma S.A. - Form 483, 2022-02-04 |
February, 2022 | FDA 483 Response | UCB Pharma S.A. - Form 483R, 2022-02-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more